Brigham and Women's Hospital - Division of Pharmacoepidemiology, United States
Disclosure information not submitted.
Impact of Risk Evaluation and Mitigation Strategies on Teratogenic Medications Among Publicly and Privately Insured Reproductive-Age Women
Monday, August 26, 20242:45 PM – 3:00 PM CEST
